← FDA DRUG APPROVALS

FDA ANDA · ANDA075919

MOMETASONE FUROATE

Sponsor: FOUGERA PHARMS

APPLICATION
ANDA075919
TYPE
ANDA
ORIGINAL APPROVAL
2007-11-29
LATEST ACTION
2019-04-04
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

MOMETASONE FUROATEPrescription
MOMETASONE FUROATE 0.1% · LOTION · TOPICAL

Approval history

2019-04-04Labeling · Supplement 6 · standardAP
2015-10-29Labeling · Supplement 3 · standardAP
2007-11-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →